Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.42) by 9.52 percent. This is a 8.57 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $15.43 million which beat the analyst consensus estimate of $13.98 million by 10.34 percent. This is a 12.53 percent increase over sales of $13.71 million the same period last year.
Pulmonx Q4 EPS $(0.38) Beats $(0.42) Estimate, Sales $15.43M Beat $13.98M Estimate
Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.42) by 9.52 percent. This is a 8.57 percent decrease over losses of $(0.35) per share from the same
